{"id":"https://openalex.org/W4404064290","doi":"https://doi.org/10.1136/jitc-2024-sitc2024.0502","title":"502 Delivery of hexameric TIGIT-Fc-LIGHT as lipid-encapsulated mRNA achieves therapeutic exposures that potentiate immune cell activation and anti-tumor activity in the setting of CPI acquired resistance","display_name":"502 Delivery of hexameric TIGIT-Fc-LIGHT as lipid-encapsulated mRNA achieves therapeutic exposures that potentiate immune cell activation and anti-tumor activity in the setting of CPI acquired resistance","publication_year":2024,"publication_date":"2024-11-01","ids":{"openalex":"https://openalex.org/W4404064290","doi":"https://doi.org/10.1136/jitc-2024-sitc2024.0502"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2024-sitc2024.0502","doi":"https://doi.org/10.1136/jitc-2024-sitc2024.0502","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2024-sitc2024.0502","pdf_url":null,"source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1136/jitc-2024-sitc2024.0502","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087966663","display_name":"Casey W. Shuptrine","orcid":"https://orcid.org/0000-0003-0138-9313","observed_orcids":["https://orcid.org/0000-0003-0138-9313"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Casey W Shuptrine","raw_affiliation_strings":["Shattuck Labs, Inc., Durham, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shattuck Labs, Inc., Durham, NC, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114524756","display_name":"Julia Satiaputra","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799971621","display_name":"Harry Perkins Institute of Medical Research","ror":"https://ror.org/02xz7d723","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2799971621"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Julia Satiaputra","raw_affiliation_strings":["Harry Perkins Institute of Medical Research, Nedlands, WA, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Harry Perkins Institute of Medical Research, Nedlands, WA, Australia","institution_ids":["https://openalex.org/I2799971621"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046833961","display_name":"Noriteru Doi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799971621","display_name":"Harry Perkins Institute of Medical Research","ror":"https://ror.org/02xz7d723","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2799971621"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Noriteru Doi","raw_affiliation_strings":["Harry Perkins Institute of Medical Research, Nedlands, WA, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Harry Perkins Institute of Medical Research, Nedlands, WA, Australia","institution_ids":["https://openalex.org/I2799971621"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020701910","display_name":"Yuhui Chen","orcid":"https://orcid.org/0009-0006-9347-3481","observed_orcids":["https://orcid.org/0009-0006-9347-3481"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yuhui Chen","raw_affiliation_strings":["Shattuck Labs, Inc., Durham, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shattuck Labs, Inc., Durham, NC, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055678278","display_name":"Jayalakshmi Miriyala","orcid":"https://orcid.org/0009-0005-8151-7064","observed_orcids":["https://orcid.org/0009-0005-8151-7064"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jayalakshmi Miriyala","raw_affiliation_strings":["Shattuck Labs, Inc., Durham, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shattuck Labs, Inc., Durham, NC, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035830185","display_name":"Karen L. Lenz","orcid":"https://orcid.org/0009-0002-0541-3448","observed_orcids":["https://orcid.org/0009-0002-0541-3448"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Karen Lenz","raw_affiliation_strings":["Shattuck Labs, Inc., Durham, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shattuck Labs, Inc., Durham, NC, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069904142","display_name":"Thuy\u2010Ai Nguyen","orcid":"https://orcid.org/0000-0001-8778-0078","observed_orcids":["https://orcid.org/0000-0001-8778-0078"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thuy-Ai T Nguyen","raw_affiliation_strings":["Shattuck Labs, Inc., Durham, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shattuck Labs, Inc., Durham, NC, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Jenn Michaux","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jenn Michaux","raw_affiliation_strings":["Shattuck Labs, Inc., Durham, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shattuck Labs, Inc., Durham, NC, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022179504","display_name":"Yisel A. Rivera-Molina","orcid":"https://orcid.org/0009-0003-9083-6169","observed_orcids":["https://orcid.org/0009-0003-9083-6169"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yisel Rivera-Molina","raw_affiliation_strings":["The University of Texas MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The University of Texas MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060089315","display_name":"Marc Morra","orcid":"https://orcid.org/0009-0002-5170-7682","observed_orcids":["https://orcid.org/0009-0002-5170-7682"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marc Morra","raw_affiliation_strings":["Shattuck Labs, Inc., Durham, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shattuck Labs, Inc., Durham, NC, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001670202","display_name":"Taylor Houghton Schreiber","orcid":"https://orcid.org/0000-0002-8070-1303","observed_orcids":["https://orcid.org/0000-0002-8070-1303"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Taylor H Schreiber","raw_affiliation_strings":["Shattuck Labs, Inc., Durham, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shattuck Labs, Inc., Durham, NC, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066794430","display_name":"Ruth Gan\u00df","orcid":"https://orcid.org/0000-0002-5551-045X","observed_orcids":["https://orcid.org/0000-0002-5551-045X"]},"institutions":[{"id":"https://openalex.org/I2799971621","display_name":"Harry Perkins Institute of Medical Research","ror":"https://ror.org/02xz7d723","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2799971621"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Ruth Ganss","raw_affiliation_strings":["Western Australian Institute for Medical Research, Perth, WA, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Western Australian Institute for Medical Research, Perth, WA, Australia","institution_ids":["https://openalex.org/I2799971621"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5033794726","display_name":"George J. Fromm","orcid":"https://orcid.org/0000-0002-7049-0274","observed_orcids":["https://orcid.org/0000-0002-7049-0274"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"George Fromm","raw_affiliation_strings":["Shattuck Labs, Inc., Durham, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Shattuck Labs, Inc., Durham, NC, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A566","last_page":"A566"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.98580002784729,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.98580002784729,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.010900000110268593,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lipid-nanoparticles","display_name":"lipid nanoparticles","score":0.5379999876022339},{"id":"https://openalex.org/keywords/light","display_name":"light","score":0.6050000190734863},{"id":"https://openalex.org/keywords/tumor-associated-macrophages","display_name":"tumor-associated macrophages","score":0.628000020980835},{"id":"https://openalex.org/keywords/tumor-associated-neutrophils","display_name":"tumor-associated neutrophils","score":0.6880000233650208},{"id":"https://openalex.org/keywords/tumor-associated-t-cells","display_name":"tumor-associated T cells","score":0.5730000138282776},{"id":"https://openalex.org/keywords/tumor-associated-b-cells","display_name":"tumor-associated B cells","score":0.5920000076293945}],"concepts":[{"id":"https://openalex.org/C2779118045","wikidata":"https://www.wikidata.org/wiki/Q21114021","display_name":"TIGIT","level":4,"score":0.8631973266601562},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5499434471130371},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.44909602403640747},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4489452540874481},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4471825659275055},{"id":"https://openalex.org/C105580179","wikidata":"https://www.wikidata.org/wiki/Q188928","display_name":"Messenger RNA","level":3,"score":0.42618656158447266},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.30466902256011963},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.23080140352249146},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2052554488182068},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.14520955085754395},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.13017860054969788}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1136/jitc-2024-sitc2024.0502","doi":"https://doi.org/10.1136/jitc-2024-sitc2024.0502","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2024-sitc2024.0502","pdf_url":null,"source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2024-sitc2024.0502","doi":"https://doi.org/10.1136/jitc-2024-sitc2024.0502","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2024-sitc2024.0502","pdf_url":null,"source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4285077759","https://openalex.org/W3213891135","https://openalex.org/W4282963179","https://openalex.org/W3180738747","https://openalex.org/W7161156681","https://openalex.org/W3093857245","https://openalex.org/W4388126151","https://openalex.org/W3180755291","https://openalex.org/W4295817542","https://openalex.org/W4410947262"],"abstract_inverted_index":{"Background":[0],"Previously,":[1],"we":[2],"characterized":[3],"the":[4,12,48,78,100,106,111,115,132,148,151,263,315,343,360,390,414],"bispecific":[5],"Fc":[6],"fusion":[7,168,253],"protein":[8,169,265,369],"(TIGIT-Fc-LIGHT)":[9],"that":[10,40,108,120,146],"blocks":[11],"PVR":[13],"checkpoint":[14,122,159],"axis":[15],"and":[16,61,86,134,161,170,174,187,227,236,273,302,306,333,362,381,389,412,421,425,427],"agonizes":[17],"TNFRs":[18,80],"through":[19,59],"LIGHT.":[20],"In":[21,239,314],"a":[22,65,90,365,397,430],"preclinical":[23],"tumor":[24,121,282,307,363,374],"model":[25],"of":[26,51,102,114,150,185,222,242,250,309,329,335,345,352,386,416],"acquired":[27],"resistance":[28],"to":[29,34,64,73,89,105,131,154,247,262,392],"PD-1":[30],"blockade":[31],"(CT26/AR),":[32],"exposure":[33,104,259,370],"TIGIT-Fc-LIGHT":[35,130,136,167,186,245,320,353,368],"promoted":[36],"antitumor":[37],"activity,":[38],"suggesting":[39],"immune":[41,163,195,304,378],"costimulation":[42],"mediated":[43],"by":[44,229,266,411,429],"LIGHT":[45,54,63],"may":[46,92],"broaden":[47],"clinical":[49],"utility":[50],"TIGIT":[52,126],"blockade.":[53],"can":[55],"promote":[56,155],"vascular":[57,66],"remodeling":[58],"LTbR/HVEM":[60],"linking":[62],"targeting":[67],"peptide":[68],"(VTP)":[69],"is":[70,137],"one":[71],"strategy":[72],"enrich":[74],"HEV/TLS":[75,157,206],"formation":[76],"in":[77,99,255,271,280,287,291,356,359,400],"TME.":[79],"(e.g.":[81],"HVEM/LTbR)":[82],"are":[83],"kinetically":[84],"regulated":[85],"localizing":[87],"co-stimulation":[88],"tissue":[91],"not":[93],"be":[94],"sufficient":[95],"for":[96,231],"maximum":[97],"efficacy":[98],"absence":[101],"durable":[103],"TNF-ligand":[107],"aligns":[109],"with":[110,289,298,373,413],"expression":[112,149,184,358],"pattern":[113],"target":[116],"receptor.":[117],"We":[118],"hypothesized":[119],"receptor":[123],"engagement":[124],"via":[125],"could":[127,142,395],"also":[128],"localize":[129],"TME":[133],"when":[135],"delivered":[138,175],"as":[139,347],"an":[140,417],"mRNA,":[141],"prolong":[143],"therapeutic":[144],"exposures":[145],"match":[147],"cognate":[152],"TNF-receptors;":[153],"combined":[156],"formation,":[158,327],"blockade,":[160],"anti-tumor":[162,294,382],"responses.":[164],"Methods":[165],"Mouse":[166],"mRNA/LNP":[171,243],"were":[172,189,194,201,215,225],"synthesized":[173],"into":[176],"na\u00efve":[177],"or":[178],"CT26/AR":[179],"bearing":[180,210],"Balb/c":[181],"mice.":[182],"Serum/tissue":[183],"cytokines":[188,305],"assessed":[190,228],"using":[191,197],"MSD.":[192],"TIL":[193],"phenotyped":[196],"flow":[198],"cytometry.":[199],"Tumors":[200],"measured":[202],"3x":[203],"weekly.":[204],"For":[205],"analysis,":[207],"RIP-Tag":[208,316],"mice":[209],"established":[211],"pancreatic":[212,317],"neuroendocrine":[213,318],"tumors":[214,224],"given":[216],"mTIGIT-Fc-LIGHT":[217],"IV.":[218],"After":[219],"2":[220],"weeks":[221],"treatment,":[223],"isolated":[226],"IF":[230],"MECA79,":[232],"CD3,":[233],"CD31,":[234],"CD68":[235],"F4/80.":[237],"Results":[238],"vivo":[240],"delivery":[241,351],"encoding":[244],"led":[246],"rapid":[248],"production":[249],"functional":[251],"hexameric":[252],"proteins":[254],"vivo,":[256],"increasing":[257],"overall":[258],"(AUC)":[260],"relative":[261],"recombinant":[264],"~28-fold":[267],"over":[268],"96":[269],"hours":[270],"serum":[272,300,361],"135-fold":[274],"higher":[275],"within":[276],"tumors.":[277],"This":[278,293],"resulted":[279,355],"significant":[281,398],"growth":[283],"delay,":[284],"which":[285],"improved":[286],"combination":[288],"anti-PDL1":[290],"CT26/AR.":[292],"activity":[295],"was":[296,371],"associated":[297,372],"increased":[299,321],"innate":[301],"adaptive":[303],"infiltration":[308,334,380],"antigen-specific":[310],"CD8+":[311],"T":[312,337],"cells.":[313,338],"model,":[319],"intratumoral":[322,330],"MECA79":[323],"staining":[324],"(HEV),":[325],"TLS":[326],"activation":[328],"myeloid":[331],"cells,":[332],"cytotoxic":[336],"Conclusions":[339],"Our":[340],"findings":[341],"underscore":[342],"potential":[344],"biologics":[346],"lipid-encapsulated":[348],"mRNAs.":[349],"The":[350,384],"mRNA":[354,387],"high":[357],"following":[364],"single":[366],"administration.":[367],"vasculature":[375],"remodeling,":[376],"promoting":[377],"cell":[379],"efficacy.":[383],"versatility":[385],"therapeutics":[388],"ability":[391],"fine-tune":[393],"expression/exposure":[394],"mark":[396],"advancement":[399],"immunotherapy.":[401],"Ethics":[402],"Approval":[403],"All":[404],"murine":[405],"animal":[406],"studies":[407],"have":[408],"been":[409],"conducted":[410],"approval":[415],"Institutional":[418],"Animal":[419],"Care":[420],"Use":[422],"Committee":[423],"(IACUC)":[424],"reviewed":[426],"approved":[428],"licensed":[431],"veterinarian.":[432]},"counts_by_year":[],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2024-11-06T00:00:00"}